{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:39:59Z","timestamp":1790303999082,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":5794,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.nurt.2007.07.005","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T06:23:53Z","timestamp":1193120633000},"page":"580-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Targeting MMPs in Acute and Chronic Neurological Conditions"],"prefix":"10.1016","volume":"4","author":[{"given":"V. Wee","family":"Yong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti M.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Stirling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nurt.2007.07.005_bib1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35081571","article-title":"Metalloproteinases in biology and pathology of the nervous system","volume":"2","author":"Yong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nri1418","article-title":"Matrix metalloproteinases as modulators of inflammation and innate immunity","volume":"4","author":"Parks","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10555-006-7890-0","article-title":"Degradomics","volume":"25","author":"Overall","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.nurt.2007.07.005_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodeling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.nurt.2007.07.005_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","article-title":"How matrix metalloproteinases regulate cell behavior","volume":"17","author":"Sternlicht","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.nurt.2007.07.005_bib6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","article-title":"Matrix metalloproteinases: they\u2019re not just for matrix anymore!","volume":"13","author":"McCawley","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.nurt.2007.07.005_bib7","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nrd2308","article-title":"Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases","volume":"6","author":"Hu","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.nurt.2007.07.005_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-2236(97)01169-7","article-title":"Matrix metalloproteinases and diseases of the central nervous system","volume":"21","author":"Yong","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ceb.2004.07.010","article-title":"Regulation of matrix biology by matrix metalloproteinases","volume":"16","author":"Mort","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.nurt.2007.07.005_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jcp.20948","article-title":"Regulation of matrix metalloproteinase gene expression","volume":"211","author":"Yan","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.nurt.2007.07.005_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/glia.20478","article-title":"Metalloproteinases (MMPs and ADAMs) are enriched in microglia compared to leukocytes and they link microglia activation with cytokine levels","volume":"55","author":"Nuttall","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.nurt.2007.07.005_bib13","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.4049\/jimmunol.173.8.5209","article-title":"Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis","volume":"173","author":"Toft-Hansen","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib14","unstructured":"Agrawal SM, Lau L, Yong VW. MMPs in the central nervous system: where the good guys go bad, in issue of \u201cMatrix metalloproteinases,\u201d Seminars in Cell and Developmental Biology. (In press)."},{"key":"10.1016\/j.nurt.2007.07.005_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-3806(95)00079-S","article-title":"MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization","volume":"88","author":"Canete Soler","year":"1995","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib16","first-page":"573","article-title":"Membrane-type 5 matrix metalloproteinase is expressed in differentiated neurons and regulates axonal growth","volume":"12","author":"Hayashita-Kinoh","year":"2001","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.nurt.2007.07.005_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/1097-4547(20000815)61:4<396::AID-JNR6>3.0.CO;2-S","article-title":"Regulation of tissue inhibitor of metalloproteinase-3 (Timp-3) mRNA expression during rat CNS development","volume":"61","author":"Jaworski","year":"2000","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cne.20659","article-title":"A disintegrin and metalloprotease 21 (ADAM21) is associated with neurogenesis and axonal growth in developing and adult rodent CNS","volume":"490","author":"Yang","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)80064-1","article-title":"MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover","volume":"99","author":"Holmbeck","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.07.005_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1044-7431(03)00196-9","article-title":"MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum","volume":"24","author":"Vaillant","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/14734220500247646","article-title":"The role of matrix metalloproteinases in the morphogenesis of the cerebellar cortex","volume":"4","author":"Luo","year":"2005","journal-title":"Cerebellum"},{"key":"10.1016\/j.nurt.2007.07.005_bib22","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1523\/JNEUROSCI.22-18-08091.2002","article-title":"Metalloproteases and guidance of retinal axons in the developing visual system","volume":"22","author":"Webber","year":"2002","journal-title":"J Neuroscience"},{"key":"10.1016\/j.nurt.2007.07.005_bib23","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1523\/JNEUROSCI.1880-05.2006","article-title":"Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice","volume":"26","author":"Larsen","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib24","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.yexcr.2005.11.014","article-title":"The function of neurofascin155 in oligodendrocytes is regulated by metalloprotease-mediated cleavage and ectodomain shedding","volume":"312","author":"Maier","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000088455","article-title":"Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study","volume":"27","author":"Ulrich","year":"2005","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.febslet.2004.03.070","article-title":"Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain","volume":"567","author":"Dzwonek","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nurt.2007.07.005_bib27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03565.x","article-title":"Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity","volume":"96","author":"Meighan","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.nurt.2007.07.005_bib28","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1523\/JNEUROSCI.4359-05.2006","article-title":"Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory","volume":"26","author":"Nagy","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.21273","article-title":"Matrix metalloproteinases in brain development and remodeling: Synaptic functions and targets","author":"Ethell","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrn1807","article-title":"Metalloproteinases: Mediators of pathology and regeneration in the CNS","volume":"6","author":"Yong","year":"2005","journal-title":"Nature Reviews Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib31","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1523\/JNEUROSCI.23-35-11127.2003","article-title":"Matrix metalloproteinase-9 (MMP-9) facilitates remyelination by processing the inhibitory NG2 proteoglycan","volume":"23","author":"Larsen","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib32","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1242\/jcs.01324","article-title":"Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor","volume":"117","author":"Walmsley","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.nurt.2007.07.005_bib33","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1074\/jbc.M307974200","article-title":"Evidence for a critical role of the tumor necrosis factor alpha convertase (TACE) in ectodomain shedding of the p75 neurotrophin receptor (p75NTR)","volume":"279","author":"Weskamp","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2007.07.005_bib34","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1523\/JNEUROSCI.1993-06.2006","article-title":"Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury","volume":"26","author":"Hsu","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib35","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1089\/neu.2006.23.1750","article-title":"Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats","volume":"23","author":"Pizzi","year":"2006","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.nurt.2007.07.005_bib36","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1523\/JNEUROSCI.0200-07.2007","article-title":"CNS progenitor cells promote a permissive environment for neurite outgrowth via a matrix metalloproteinase-2-dependent mechanism","volume":"27","author":"Zhang","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nm1387","article-title":"Role of matrix metalloproteinases in delayed cortical responses after stroke","volume":"12","author":"Zhao","year":"2006","journal-title":"Nat Med"},{"issue":"suppl 2","key":"10.1016\/j.nurt.2007.07.005_bib38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.STR.0000253500.32979.d1","article-title":"Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke","volume":"38","author":"Zhao","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nurt.2007.07.005_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ana.1236","article-title":"Matrix metalloproteinases in multiple sclerosis: is it time for a treatment trial?","volume":"50","author":"Rosenberg","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-0173(01)00101-1","article-title":"Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis","volume":"36","author":"Leppert","year":"2001","journal-title":"Brain Res Brain Res Rev"},{"issue":"suppl 3","key":"10.1016\/j.nurt.2007.07.005_bib41","first-page":"S32","article-title":"Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators","volume":"68","author":"Yong","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nurt.2007.07.005_bib42","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","article-title":"An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization","volume":"19","author":"Weaver","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.nurt.2007.07.005_bib43","doi-asserted-by":"crossref","first-page":"7526","DOI":"10.1523\/JNEUROSCI.22-17-07526.2002","article-title":"Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events","volume":"22","author":"Noble","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib44","doi-asserted-by":"crossref","first-page":"10107","DOI":"10.1523\/JNEUROSCI.23-31-10107.2003","article-title":"An adverse role for matrix metalloproteinase (MMP)-12 following spinal cord injury in mice","volume":"23","author":"Wells","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1460-9568.2004.03829.x","article-title":"Matrix metalloproteinase (MMP)-12 expression has a negative impact on sensorimotor function following intracerebral haemorrhage in mice","volume":"21","author":"Wells","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib46","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.STR.0000126827.69286.90","article-title":"Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome","volume":"35","author":"Alvarez-Sabin","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.nurt.2007.07.005_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0006-8993(00)03294-7","article-title":"Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures","volume":"893","author":"Rosenberg","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1523\/JNEUROSCI.4243-03.2004","article-title":"Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia","volume":"24","author":"Lee","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib49","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1161\/01.STR.0000170641.01047.cc","article-title":"A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke","volume":"36","author":"Rosell","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.nurt.2007.07.005_bib50","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/01.WCB.0000122747.72175.47","article-title":"Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation","volume":"24","author":"Lee","year":"2004","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nurt.2007.07.005_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/glia.20169","article-title":"Multiple roles for MMPs and TIMPs in cerebral ischemia","volume":"50","author":"Cunningham","year":"2005","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.nurt.2007.07.005_bib52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.STR.0000254477.34231.cb","article-title":"Microglial activation and matrix protease generation during focal cerebral ischemia","volume":"38","author":"del Zoppo","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.nurt.2007.07.005_bib53","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1172\/JCI117578","article-title":"Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases","volume":"94","author":"Gijbels","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nurt.2007.07.005_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01796266","article-title":"Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790","volume":"44","author":"Hewson","year":"1995","journal-title":"Inflammation Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00179-8","article-title":"Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview","volume":"72","author":"Chandler","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-5728(00)00275-7","article-title":"Distinct roles for matrix metalloproteinase-2 and alpha4 integrin in autoimmune T cell extravasation and residency in brain parenchyma during experimental autoimmune encephalomyelitis","volume":"109","author":"Graesser","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneuroim.2004.05.010","article-title":"Inhibition of MMP-dependent chemotaxis and amelioration of experimental autoimmune uveitis with a selective metalloproteinase-2 and -9 inhibitor","volume":"155","author":"El-Shabrawi","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib58","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jnr.20255","article-title":"Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis","volume":"78","author":"Marracci","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib59","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jneuroim.2003.11.021","article-title":"Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis","volume":"148","author":"Morini","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0165-5728(02)00269-2","article-title":"Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis","volume":"131","author":"Marracci","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nurt.2007.07.005_bib61","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.nbd.2006.10.019","article-title":"The role of matrix metalloproteinases in infant traumatic brain injury","volume":"25","author":"Sifringer","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nurt.2007.07.005_bib62","first-page":"30","article-title":"The effects of acute and extended inhibition of matrix metalloproteinases on demyelination and functional recovery after spinal cord injury","volume":"2","author":"Trivedi","year":"2005","journal-title":"Int J Neuroprotect Neuroregen"},{"key":"10.1016\/j.nurt.2007.07.005_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.expneurol.2006.01.026","article-title":"The matrix metalloproteinases inhibitor Ro 28-2653 extends survival in transgenic ALS mice","volume":"200","author":"Lorenzl","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.expneurol.2007.01.036","article-title":"Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"205","author":"Kiaei","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib65","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0360-3016(02)03743-4","article-title":"Phase II study of high central dose gamma knife radiosurgery and marimastat in patients with recurrent malignant glioma","volume":"54","author":"Larson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nurt.2007.07.005_bib66","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2002.20.5.1383","article-title":"Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme","volume":"20","author":"Groves","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nurt.2007.07.005_bib67","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11060-005-9098-5","article-title":"Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation","volume":"78","author":"Levin","year":"2006","journal-title":"J Neurooncol"},{"key":"10.1016\/j.nurt.2007.07.005_bib68","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ana.410400607","article-title":"Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9","volume":"40","author":"Stuve","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib69","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ana.410400606","article-title":"Interferon beta-1b inhibits gelatinase secretion and in vivo migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis","volume":"40","author":"Leppert","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/10799900152434367","article-title":"Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta","volume":"21","author":"Bartholome","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib71","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1212\/WNL.59.6.802","article-title":"Differential mechanisms of action of interferon-\u03b2 and glatiramer acetate in MS","volume":"59","author":"Yong","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nurt.2007.07.005_bib72","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(03)00587-8","article-title":"Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis","volume":"2","author":"Opdenakker","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib73","doi-asserted-by":"crossref","first-page":"47461","DOI":"10.1074\/jbc.M204824200","article-title":"Deficiency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation","volume":"277","author":"Chintala","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2007.07.005_bib74","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.1563-05.2005","article-title":"A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia","volume":"25","author":"Gu","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib75","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1073634","article-title":"S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death","volume":"297","author":"Gu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.005_bib76","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nn1127","article-title":"HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration","volume":"6","author":"Zhang","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib77","doi-asserted-by":"crossref","first-page":"10281","DOI":"10.1523\/JNEUROSCI.2806-06.2006","article-title":"Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice","volume":"26","author":"Xue","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.nurt.2007.07.005_bib78","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(02)01079-6","article-title":"Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury","volume":"111","author":"Li","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.nurt.2007.07.005_bib79","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","article-title":"Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact","volume":"96","author":"Van den Steen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.nurt.2007.07.005_bib80","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.289.5482.1202","article-title":"Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3","volume":"289","author":"McQuibban","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.005_bib81","doi-asserted-by":"crossref","first-page":"43503","DOI":"10.1074\/jbc.M107736200","article-title":"Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1","volume":"276","author":"McQuibban","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2007.07.005_bib82","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1046\/j.1432-1033.2003.03760.x","article-title":"Gelatinase B\/MMP-9 and neutrophil collagenase\/MMP-8 process the chemokines human GCP-2\/CXCL6, ENA-78\/CXCL5 and mouse GCP-2\/LIX and modulate their physiological activities","volume":"270","author":"Van Den Steen","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nurt.2007.07.005_bib83","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.bjc.6603043","article-title":"Towards third generation matrix metalloproteinase inhibitors for cancer therapy","volume":"94","author":"Overall","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nurt.2007.07.005_bib84","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/138161207779313551","article-title":"Matrix metalloproteinases as valid clinical targets","volume":"13","author":"Fingleton","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nurt.2007.07.005_bib85","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1126\/science.1067100","article-title":"Matrix metalloproteinase inhibitors and cancer: trials and tribulations","volume":"295","author":"Coussens","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nurt.2007.07.005_bib86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc745","article-title":"New functions for the matrix metalloproteinases in cancer progression","volume":"2","author":"Egeblad","year":"2002","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.nurt.2007.07.005_bib87","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0765.1984.tb01334.x","article-title":"Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease","volume":"19","author":"Golub","year":"1984","journal-title":"J Periodontal Res"},{"key":"10.1016\/j.nurt.2007.07.005_bib88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-2952(96)00168-2","article-title":"The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors","volume":"52","author":"Paemen","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nurt.2007.07.005_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/0929867013373598","article-title":"Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity","volume":"8","author":"Ryan","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nurt.2007.07.005_bib90","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.nurt.2007.07.005_bib91","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.10092","article-title":"Inhibition of autoimmune encephalomyelitis by a tetracycline","volume":"51","author":"Popovic","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib92","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.10353","article-title":"Effect of minocycline in experimental autoimmune encephalomyelitis","volume":"52","author":"Nessler","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib93","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.nbd.2006.10.022","article-title":"Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation","volume":"25","author":"Maier","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nurt.2007.07.005_bib94","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.20111","article-title":"Minocycline reduces gadolinium-enhancing MRI lesions in multiple sclerosis","volume":"55","author":"Metz","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib95","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1352458506070319","article-title":"The clinical response to minocycline in MS is accompanied by immune changes","volume":"13","author":"Zabad","year":"2007","journal-title":"Multiple Sclerosis J"},{"key":"10.1016\/j.nurt.2007.07.005_bib96","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1474-4422(04)00937-8","article-title":"The promise of minocycline in neurology","volume":"3","author":"Yong","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nurt.2007.07.005_bib97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins","volume":"2","author":"Kwak","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.nurt.2007.07.005_bib98","doi-asserted-by":"crossref","first-page":"16948","DOI":"10.1074\/jbc.M700158200","article-title":"ADAM-15\/metargidin mediates homotypic aggregation of human T lymphocytes and heterotypic interactions of T lymphocytes with intestinal epithelial cells","volume":"282","author":"Charrier","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nurt.2007.07.005_bib99","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.emboj.7601520","article-title":"Metalloproteases regulate T-cell proliferation and effector function via LAG-3","volume":"26","author":"Li","year":"2007","journal-title":"Embo J"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300613X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792300613X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurt.2007.07.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:40:05Z","timestamp":1761806405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792300613X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S187874792300613X"],"URL":"https:\/\/doi.org\/10.1016\/j.nurt.2007.07.005","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting MMPs in Acute and Chronic Neurological Conditions","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nurt.2007.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}